Author
Listed:
- Nisha Singh
(University of Oxford)
- Amy C. Halliday
(University of Oxford)
- Justyn M. Thomas
(University of Oxford)
- Olga V. Kuznetsova
(University of Oxford)
- Rhiannon Baldwin
(University of Oxford)
- Esther C. Y. Woon
(University of Oxford
Present address: Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543)
- Parvinder K. Aley
(University of Oxford)
- Ivi Antoniadou
(University of Oxford)
- Trevor Sharp
(University of Oxford)
- Sridhar R. Vasudevan
(University of Oxford)
- Grant C. Churchill
(University of Oxford)
Abstract
Lithium is the most effective mood stabilizer for the treatment of bipolar disorder, but it is toxic at only twice the therapeutic dosage and has many undesirable side effects. It is likely that a small molecule could be found with lithium-like efficacy but without toxicity through target-based drug discovery; however, therapeutic target of lithium remains equivocal. Inositol monophosphatase is a possible target but no bioavailable inhibitors exist. Here we report that the antioxidant ebselen inhibits inositol monophosphatase and induces lithium-like effects on mouse behaviour, which are reversed with inositol, consistent with a mechanism involving inhibition of inositol recycling. Ebselen is part of the National Institutes of Health Clinical Collection, a chemical library of bioavailable drugs considered clinically safe but without proven use. Therefore, ebselen represents a lithium mimetic with the potential both to validate inositol monophosphatase inhibition as a treatment for bipolar disorder and to serve as a treatment itself.
Suggested Citation
Nisha Singh & Amy C. Halliday & Justyn M. Thomas & Olga V. Kuznetsova & Rhiannon Baldwin & Esther C. Y. Woon & Parvinder K. Aley & Ivi Antoniadou & Trevor Sharp & Sridhar R. Vasudevan & Grant C. Churc, 2013.
"A safe lithium mimetic for bipolar disorder,"
Nature Communications, Nature, vol. 4(1), pages 1-7, June.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2320
DOI: 10.1038/ncomms2320
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2320. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.